Registration for a live webinar on 'Innovative Vaccines and Viral Pathogenesis: Insights from Recent Monkeypox (Mpox) Research' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Learning objectives
- Defining heart failure
- What are the different ways the heart can fail?
- What are the potential etiologies of heart failure?
- What are the clinical signs of heart failure?
- Where does the fluid go? (Dogs vs. cats)
- Neurohormonal compensatory systems
- Parameters affecting heart failure
- Drug treatment options (1)
- Diuretics
- Which diuretic to choose?
- Drug treatment options (2)
- Which vasodilator to choose?
- Drug treatment options (3)
- Inotropes
- Which inotrope to choose?
- Drug treatment options (4)
- Heart rate optimization
- Which negative chronotrope to use for Afib?
- Drug treatment options (5)
- RAAS
- Which neurohormonal modulator to choose?
- Summary: pharmacologic treatment of CHF
- Lifestyle modifications for heart failure patients
- What are the goals of heart failure treatment?
- Quick review
Topics Covered
- Define heart failure
- Hemodynamic determinants of cardiac output
- Clinical signs of “forward” vs. “backward” heart failure
- How the body’s neurohormonal compensatory systems respond to heart failure
- Categories of hemodynamic and neurohormonal abnormalities in heart failure that can be targeted with drug therapy
- Diuretics, vasodilators, positive inotropes, negative chronotropes, and drugs that modulate the RAAS and SNS systems
- Appropriate drug treatment plans for patients in heart failure (acute and chronic)
- Appropriate lifestyle changes to owners of patients with chronic CHF
Links
Categories:
Therapeutic Areas:
Talk Citation
Ward, J. (2018, December 30). Pathophysiology and treatment of congestive heart failure in dogs and cats [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved November 21, 2024, from https://doi.org/10.69645/KGQG2214.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Jessica Ward has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
A selection of talks on Clinical Practice
Transcript
Please wait while the transcript is being prepared...
0:00
Welcome. My name is Jessica Ward,
and I'm a board-certified veterinary cardiologist and
assistant professor at the Iowa State University College of Veterinary Medicine.
Today, we'll be discussing basic concepts of the pathophysiology
and treatment of congestive heart failure in dogs and cats.
0:20
The first half of this lecture will introduce
concepts regarding pathophysiology of heart failure.
What is heart failure as a syndrome, how do we define it,
what are the hemodynamic determinants of cardiac output,
what are the clinical signs and syndromes associated with heart failure, and finally,
how do the body's neurohormonal compensatory systems respond to heart failure?
The goal of this pathophysiology review is to provide background
for understanding options for pharmacologic management of heart failure.
These two topics are inextricably linked.
We treat heart failure by giving medications that address
both hemodynamic and neurohormonal derangements.
1:01
Heart failure by definition is a clinical syndrome,
not a specific ideologic diagnosis,
wherein the heart cannot pump adequate volume of blood to both meet tissue demand for
oxygen and nutrient delivery while preventing
backup of blood and congestion or fluid accumulation.
Those are the jobs of the heart.
It's supposed to pump blood forward and meet the demands
of the body while preventing blood from backing up.
Heart failure occurs when the heart fails at one or both of those two jobs.
A key conceptual differentiation is between heart failure and hypovolemic shock.
In hypovolemic shock, the body is also unable to meet its tissue demands.
However, in hypovolemic shock it's because there's not
physically enough blood in the system for the heart to pump.
In contrast, in heart failure,
there's plenty of blood in the circulation.
In fact, sometimes there's too much intravascular volume.
The problem is that the heart is diseased and unable to handle that volume of blood.
Heart failure is not in and of itself a diagnosis.
It is a syndrome that occurs secondary to many different heart diseases.
Hypertrophic cardiomyopathy, dilated cardiomyopathy,
degenerative mitral valve disease,
patent ductus arteriosus, heart failure is
an end result of many different diseases such as any of these.
The term heart failure is thus more a marker of
disease severity rather than a description of any particular disease.
When using various staging systems such as
the ACVIM staging system or
the International Small Animal Cardiac Health Council staging system,
heart failure marks the onset of the more advanced stages of disease.
Hide